Company intelligence / Profile preview

Cecoura Therapeutics

Oxford, Oxfordshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Cecoura Therapeutics is a biotechnology company dedicated to developing innovative, non-hormonal treatments for endometriosis and associated chronic pain. Founded as a spin-out from the University of Oxford, the company leverages research into the P2X3 receptor to address the significant unmet medical need in women's health. Their lead programs aim to provide effective pain relief without the side effects typically associated with current hormonal therapies. Cecoura is positioned at the intersection of precision medicine and women's health, focusing on improving the quality of life for millions of patients worldwide.

Therapeutic areas: Women's Health
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Cecoura Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cecoura Therapeutics.

Explore the full profile